RoosterBio Blog

“V” for Value Emerging new therapeutic agents based on extracellular vesicle and/or exosome modalities can offer great hope against unmet clinical needs. [1, 2, 3, 4, 5, 6]  Nevertheless, it’s ... More

As the basis for safe use in over 1,000 worldwide clinical trials targeting all broad disease indications, [1] mesenchymal stem/stromal cells (MSCs) have nevertheless been likened to a double-edged sword. ... More